BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15984414)

  • 1. Microdamage accumulation in the monkey vertebra does not occur when bone turnover is suppressed by 50% or less with estrogen or raloxifene.
    Li J; Sato M; Jerome C; Turner CH; Fan Z; Burr DB
    J Bone Miner Metab; 2005; 23 Suppl():48-54. PubMed ID: 15984414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
    Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
    J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of suppressed bone remodeling by minodronic acid and alendronate on bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys.
    Mashiba T; Saito M; Yamagami Y; Tanaka M; Iwata K; Yamamoto T
    Bone; 2017 Apr; 97():184-191. PubMed ID: 28082077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of raloxifene on bone density, biomarkers, and histomorphometric and biomechanical measures in ovariectomized cynomolgus monkeys.
    Lees CJ; Register TC; Turner CH; Wang T; Stancill M; Jerome CP
    Menopause; 2002; 9(5):320-8. PubMed ID: 12218720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-Weekly Teriparatide Treatment Prevents Microdamage Accumulation in the Lumbar Vertebral Trabecular Bone of Ovariectomized Cynomolgus Monkeys.
    Yoshitake S; Mashiba T; Saito M; Fujihara R; Iwata K; Takao-Kawabata R; Yamamoto T
    Calcif Tissue Int; 2019 Apr; 104(4):402-410. PubMed ID: 30564860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats.
    Cao Y; Mori S; Mashiba T; Westmore MS; Ma L; Sato M; Akiyama T; Shi L; Komatsubara S; Miyamoto K; Norimatsu H
    J Bone Miner Res; 2002 Dec; 17(12):2237-46. PubMed ID: 12469918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys.
    Tanaka M; Mori H; Kawabata K; Mashiba T
    Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
    Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
    Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone.
    Saito M; Grynpas MD; Burr DB; Allen MR; Smith SY; Doyle N; Amizuka N; Hasegawa T; Kida Y; Marumo K; Saito H
    Bone; 2015 Apr; 73():8-15. PubMed ID: 25482210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys.
    Hotchkiss CE; Stavisky R; Nowak J; Brommage R; Lees CJ; Kaplan J
    Bone; 2001 Jul; 29(1):7-15. PubMed ID: 11472885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.
    Kostenuik PJ; Smith SY; Jolette J; Schroeder J; Pyrah I; Ominsky MS
    Bone; 2011 Aug; 49(2):151-61. PubMed ID: 21457806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
    Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
    Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
    Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.
    Mashiba T; Hui S; Turner CH; Mori S; Johnston CC; Burr DB
    Calcif Tissue Int; 2005 Sep; 77(3):180-5. PubMed ID: 16265598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey.
    Müller R; Hannan M; Smith SY; Bauss F
    J Bone Miner Res; 2004 Nov; 19(11):1787-96. PubMed ID: 15476578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.